A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in pat...

Por Chow, Laura Q. M., Eckhardt, S. Gail, O’Bryant, Cindy L., Schultz, Mary Kay, Morrow, Mark, Grolnic, Stacy, Basche, Michele, Gore, Lia
Publicado em 2007

Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials

Por Basche, Michele, Barón, Anna E., Eckhardt, S. Gail, Balducci, Lodovico, Persky, Martha, Levin, Adrah, Jackson, Nathaniel, Zeng, Chan, Vranas, Pamela, Steiner, John F.
Publicado em 2008

A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors

Por Lam, Elaine T., O'Bryant, Cindy L., Basche, Michele, Gustafson, Daniel L., Serkova, Natalie, Baron, Anna, Holden, Scott N., Dancey, Janet, Eckhardt, S. Gail, Gore, Lia
Publicado em 2008

A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies

Por Chow, Laura Q. M., Gustafson, Daniel L., O’Bryant, Cindy L., Gore, Lia, Basche, Michele, Holden, Scott N., Morrow, Mark C., Grolnic, Stacy, Creese, Brian R., Roberts, Kaye L., Davis, Kat, Addison, Russell, Eckhardt, S. Gail
Publicado em 2008

A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors

Por Jameson, Gayle S., Hamm, John T., Weiss, Glen J., Alemany, Carlos, Anthony, Stephen, Basche, Michele, Ramanathan, Ramesh K., Borad, Mitesh J., Tibes, Raoul, Cohn, Allen, Hinshaw, Ioana, Jotte, Robert, Rosen, Lee S., Hoch, Ute, Eldon, Michael A., Medve, Robert, Schroeder, Katrina, White, Erica, Von Hoff, Daniel D.
Publicado em 2012